Clinical significance of tumor markers in detection of recurrent hepatocellular carcinoma after radiofrequency ablation.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  International Journal of Molecular Medicine

• Publication date

  2010-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3892/IJMM_00000482PMID 20664960
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High serum des‐gamma‐carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma

  2009cited by this paper
• Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications.

  2008cited by this paper
• Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC.

  2008cited by this paper
• Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy.

  2008cited by this paper
• Selected Published Abstracts of Baylor Researchers

  2008cited by this paper
• Predictive factors for distant recurrence of HCV‐related hepatocellular carcinoma after radiofrequency ablation combined with chemoembolization

  2008cited by this paper
• Recurrent hepatocellular carcinoma has an increased risk of subsequent recurrence after curative treatment

  2007cited by this paper
• Analysis of Recurrence Pattern and Its Influence on Survival Outcome After Radiofrequency Ablation of Hepatocellular Carcinoma

  2007cited by this paper
• Survival and recurrences after hepatic resection or radiofrequency for hepatocellular carcinoma in cirrhotic patients: A multivariate analysis

  2007cited by this paper
• Role of tumor markers in assessment of tumor progression and prediction of outcomes in patients with hepatocellular carcinoma

  2007cited by this paper
• Serum tumor markers for detection of hepatocellular carcinoma.

  2006cited by this paper
• Prognostic significance of simultaneous measurement of three tumor markers in patients with hepatocellular carcinoma.

  2006cited by this paper
• Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers

  2006cited by this paper
• Comparing the Outcomes of Radiofrequency Ablation and Surgery in Patients With a Single Small Hepatocellular Carcinoma and Well-Preserved Hepatic Function

  2005cited by this paper
• New serological markers for hepatocellular carcinoma.

  2005cited by this paper
• Serum insulin-like growth factor-II as a serologic marker of small hepatocellular carcinoma

  2005cited by this paper
• Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation.

  2005cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• Percutaneous Radiofrequency Ablation for the Treatment of Liver Neoplasms in the Caudate Lobe Left of the Vena Cava: Electrode Placement Through the Left Lobe of the Liver Under CT-Fluoroscopic Guidance

  2005cited by this paper
• Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma.

  2004cited by this paper
• Identification of Soluble NH 2-Terminal Fragment of Glypican-3 as a Serological Marker for Early-Stage Hepatocellular Carcinoma

  2004cited by this paper
• Newer markers for hepatocellular carcinoma.

  2004cited by this paper
• Surgical Resection Versus Percutaneous Radiofrequency Ablation in the Treatment of Hepatocellular Carcinoma on Cirrhotic Liver

  2004cited by this paper
• Identification of Soluble NH2-Terminal Fragment of Glypican-3 as a Serological Marker for Early-Stage Hepatocellular Carcinoma

  2004cited by this paper
• Percutaneous radiofrequency ablation of liver neoplasms adjacent to the gastrointestinal tract after balloon catheter interposition.

  2003cited by this paper
• Radiofrequency ablation combined with chemoembolization in hepatocellular carcinoma: treatment response based on tumor size and morphology.

  2002cited by this paper
• Influencing factors for recurrence of hepatocellular carcinoma treated with radiofrequency ablation.

  2002cited by this paper
• Tumor Markers in Early Diagnosis, Follow-Up and Management of Patients with Hepatocellular Carcinoma

  2002cited by this paper
• Risk factors for distant recurrence of hepatocellular carcinoma in the liver after complete coagulation by microwave or radiofrequency ablation

  2001cited by this paper
• Recurrence of hepatocellular carcinoma: multicentric occurrence or intrahepatic metastasis? A viewpoint in terms of pathology.

  2001cited by this paper
• Multicenter prospective analysis of newly diagnosed hepatocellular carcinoma with respect to the percentage of Lens culinaris agglutinin‐reactive α‐fetoprotein 1

  2001cited by this paper
• Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status.

  2001cited by this paper
• Management of hepatocellular carcinoma: advances in diagnosis, treatment and prevention

  2001cited by this paper
• Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection.

  2000cited by this paper
• Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation

  2000cited by this paper
• Metachronous multicentric occurrence of hepatocellular carcinoma after surgical treatment - clinicopathological comparison with recurrence due to metastasis.

  1999cited by this paper
• Factors that predict intrahepatic recurrence of hepatocellular carcinoma in 81 patients initially treated by percutaneous ethanol injection

  1999cited by this paper
• The usefulness of determining des‐γ‐carboxy prothrombin by sensitive enzyme immunoassay in the early diagnosis of patients with hepatocellular carcinoma

  1998cited by this paper
• Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma

  1997cited by this paper
• Prognostic significance of Lens culinaris agglutinin A-reactive alpha-fetoprotein in small hepatocellular carcinomas.

  1996cited by this paper
• Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: Incidence and prevalence of hepatocellular carcinoma in a North American urban population

  1995cited by this paper
• Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma.

  1994cited by this paper
• Prospective study of α‐fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma

  1994cited by this paper
• A collaborative study for the evaluation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma.

  1993cited by this paper
• Risk factors for hepatocellular carcinoma among patients with chronic liver disease.

  1993cited by this paper
• A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis

  1993cited by this paper
• Lectin-reactive profiles of alpha-fetoprotein characterizing hepatocellular carcinoma and related conditions.

  1990cited by this paper
• Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma.

  1984cited by this paper
• Des-γ-Carboxy (Abnormal) Prothrombin as a Serum Marker of Primary Hepatocellular Carcinoma

  1984cited by this paper

• Predictors for hepatocellular carcinoma recurrence after microwave ablation

  2020cites this paper
• Des-gamma-carboxy prothrombin affects the survival of HCC patients with marginal liver function and curative treatment: ACRoS1402

  2020cites this paper
• Serum Dickopff 1 as a Novel Biomarker in Hepatocellular Carcinoma Diagnosis and Follow Up After Ablative Therapy

  2019cites this paper
• CMAR_A_218532 10555..10562

  2019cites this paper
• Prognostic value of PIVKA-II in hepatocellular carcinoma patients receiving curative ablation: A systematic review and meta-analysis

  2018cites this paper
• Clinical and circulating biomarkers of survival and recurrence after radiofrequency ablation in patients with hepatocellular carcinoma.

  2018cites this paper
• Antitumor Activities of the Novel Isosteviol Derivative 10C Against Liver Cancer.

  2017cites this paper
• The effect of oleuropein from olive leaf (Olea europaea) extract on Ca²⁺ homeostasis, cytotoxicity, cell cycle distribution and ROS signaling in HepG2 human hepatoma cells.

  2016cites this paper
• Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation.

  2016cites this paper
• Prognostic Role of Pre-Treatment Serum AFP-L3% in Hepatocellular Carcinoma: Systematic Review and Meta-Analysis

  2014influential citation
• Des‐γ‐carboxy prothrombin ratio measured by P‐11 and P‐16 antibodies is a novel biomarker for hepatocellular carcinoma

  2013cites this paper
• Serum VEGF as a tumor marker in patients with HCV-related liver cirrhosis and hepatocellular carcinoma.

  2013cites this paper
• The role of microRNAs in the management of liver cancer.

  2012cites this paper
• Novel Lens culinaris agglutinin-reactive fraction of a-fetoprotein: a biomarker of hepatocellular carcinoma recurrence in patients with low a-fetoprotein concentrations

  2012cites this paper
• Role of the multidisciplinary team in the diagnosis and treatment of hepatocellular carcinoma

  2012cites this paper
• Alantolactone Induces Apoptosis in HepG2 Cells through GSH Depletion, Inhibition of STAT3 Activation, and Mitochondrial Dysfunction

  2012cites this paper
• Novel Lens culinaris agglutinin-reactive fraction of α-fetoprotein: a biomarker of hepatocellular carcinoma recurrence in patients with low α-fetoprotein concentrations

  2012cites this paper
• Prediction and prevention of intrahepatic recurrence of hepatocellular carcinoma

  2012cites this paper